PL3322718T3 - Histonowe szczepionki przeciwnowotworowe - Google Patents
Histonowe szczepionki przeciwnowotworoweInfo
- Publication number
- PL3322718T3 PL3322718T3 PL16739451.9T PL16739451T PL3322718T3 PL 3322718 T3 PL3322718 T3 PL 3322718T3 PL 16739451 T PL16739451 T PL 16739451T PL 3322718 T3 PL3322718 T3 PL 3322718T3
- Authority
- PL
- Poland
- Prior art keywords
- histone
- cancer vaccines
- vaccines
- cancer
- histone anti
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15176879.3A EP3118217A1 (en) | 2015-07-15 | 2015-07-15 | Histone anti-cancer vaccines |
| PCT/EP2016/066563 WO2017009349A1 (en) | 2015-07-15 | 2016-07-12 | Histone anti-cancer vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3322718T3 true PL3322718T3 (pl) | 2024-04-22 |
Family
ID=53776323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16739451.9T PL3322718T3 (pl) | 2015-07-15 | 2016-07-12 | Histonowe szczepionki przeciwnowotworowe |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20180155403A1 (pl) |
| EP (2) | EP3118217A1 (pl) |
| ES (1) | ES2967314T3 (pl) |
| HU (1) | HUE064499T2 (pl) |
| PL (1) | PL3322718T3 (pl) |
| WO (1) | WO2017009349A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10441644B2 (en) * | 2015-05-05 | 2019-10-15 | The Regents Of The University Of California | H3.3 CTL peptides and uses thereof |
| EP4450083A3 (en) * | 2015-05-05 | 2025-01-01 | The Regents of the University of California | H3.3 ctl peptides and uses thereof |
| EP3962521A1 (en) * | 2019-05-02 | 2022-03-09 | University of Florida Research Foundation, Inc. | Compositions for treatment of diffuse intrinsic pontine glioma |
| CN112646020B (zh) * | 2019-10-11 | 2023-04-25 | 南通睿科医药科技有限公司 | 基于组蛋白h3 k27m突变肽的抗原肽及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010034042A1 (en) * | 2000-01-20 | 2001-10-25 | Srivastava Pramod K. | Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents |
| US8541002B2 (en) * | 2003-09-12 | 2013-09-24 | Agenus Inc. | Vaccine for treatment and prevention of herpes simplex virus infection |
| WO2013075237A1 (en) * | 2011-11-21 | 2013-05-30 | The Royal Institution For The Advancement Of Learning / Mcgill University | Mutations of histone proteins associated with proliferative disorders |
| US9388213B2 (en) * | 2012-09-10 | 2016-07-12 | The Rockefeller University | Polycomb repressive complex 2 (PRC2) inhibitors and uses thereof |
| US10441644B2 (en) * | 2015-05-05 | 2019-10-15 | The Regents Of The University Of California | H3.3 CTL peptides and uses thereof |
| EP4450083A3 (en) * | 2015-05-05 | 2025-01-01 | The Regents of the University of California | H3.3 ctl peptides and uses thereof |
-
2015
- 2015-07-15 EP EP15176879.3A patent/EP3118217A1/en not_active Ceased
-
2016
- 2016-07-12 WO PCT/EP2016/066563 patent/WO2017009349A1/en not_active Ceased
- 2016-07-12 ES ES16739451T patent/ES2967314T3/es active Active
- 2016-07-12 PL PL16739451.9T patent/PL3322718T3/pl unknown
- 2016-07-12 HU HUE16739451A patent/HUE064499T2/hu unknown
- 2016-07-12 US US15/735,046 patent/US20180155403A1/en not_active Abandoned
- 2016-07-12 EP EP16739451.9A patent/EP3322718B1/en active Active
-
2020
- 2020-03-27 US US16/832,465 patent/US11767352B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3322718C0 (en) | 2023-10-04 |
| WO2017009349A1 (en) | 2017-01-19 |
| EP3322718B1 (en) | 2023-10-04 |
| US20180155403A1 (en) | 2018-06-07 |
| EP3118217A1 (en) | 2017-01-18 |
| EP3322718A1 (en) | 2018-05-23 |
| HUE064499T2 (hu) | 2024-03-28 |
| US20200377562A1 (en) | 2020-12-03 |
| ES2967314T3 (es) | 2024-04-29 |
| US11767352B2 (en) | 2023-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201410971D0 (en) | Vaccine | |
| GB201518684D0 (en) | Vaccine | |
| GB201406608D0 (en) | Virus | |
| GB201409471D0 (en) | Pharmaceutical composition | |
| PL3185899T3 (pl) | Wzmocniona szczepionka wektorowa-hvt przeciwko nd-ibd | |
| SG11201702298VA (en) | Pharmaceutical preparation | |
| GB201409488D0 (en) | Pharmaceutical composition | |
| GB201409485D0 (en) | Pharmaceutical composition | |
| ZA201702086B (en) | Long acting pharmaceutical compositions | |
| IL254419A0 (en) | New pharmaceutical uses | |
| GB201522132D0 (en) | Vaccine | |
| GB2525615B (en) | Adjustable shootbolt assembly | |
| GB201419572D0 (en) | Virus | |
| PL3322718T3 (pl) | Histonowe szczepionki przeciwnowotworowe | |
| GB201616904D0 (en) | Vaccine | |
| GB201608821D0 (en) | Vaccines | |
| SI3237612T1 (sl) | Variante zaporedja | |
| PL3089740T3 (pl) | Kompozycja farmaceutyczna | |
| HUE053284T2 (hu) | Vakcina | |
| GB2529605B (en) | Pharmaceutical composition | |
| GB201603029D0 (en) | Vaccine | |
| GB201417214D0 (en) | Vaccine | |
| GB201406628D0 (en) | Vaccine | |
| GB201518917D0 (en) | Vaccination | |
| GB201521015D0 (en) | Novel pharmaceutical uses |